Publication | Open Access
Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation
52
Citations
46
References
2022
Year
VasculitisAngiopoietin-1 Derived PeptideImmunologyViral PathogenesisInnate ImmunityBiomedical EngineeringImmunotherapyCovid-19Vasculature-on-a-chip PlatformInflammationInflammatory MarkerAdverse EffectsImmune CellsVascular BiologyChronic Viral InfectionSars-cov-2 Induced InflammationAntiviral ResponseTherapeutic PeptideMedicineViral Immunity
Microfluidic polymeric blood vessel captures the adverse effects of SARS-CoV-2 on vasculature and enables identification of a therapeutic peptide that abolished virus induced cytokine storm orchestrated by the immune cells.
| Year | Citations | |
|---|---|---|
Page 1
Page 1